New Search

If you are not happy with the results below please do another search

1 search result for:

1

Rheonix receives patent for device and process that will improve workflow and lower costs of molecular diagnostic testing

Rheonix Inc., a developer of fully automated molecular diagnostics solutions, has been granted patent 9,132,398, “Integrated Microfluidic Device and Methods,” for the Rheonix CARD® cartridge, which enables assays to be performed on the company’s EncompassMDx® and Encompass Optimum™ instruments. The CARD, which stands for Chemistry and Reagent Device, will make molecular diagnostics simpler and easier […]